You are here
Mood Symptoms Seen Even with Shorter IVF Tactic
(Reuters Health) - Women who undergo fertility treatment with drugs known as GnRH-agonists run a risk of depression and anxiety symptoms, even if they have a relatively shorter course of therapy, a new study suggests.
Published in the journal of Fertility and Sterility, the report concludes that the medications themselves may not be triggering mood symptoms, but that another factor -- like the stress of infertility treatment -- may be at work.
The study followed 108 Israeli women undergoing in-vitro fertilization (IVF) at one infertility treatment center. As part of the treatment, the women received injections of a gonadotropin-releasing hormone agonist (GnRH-a), one of the drugs used to help stimulate the ovaries to produce eggs.